Eli Lilly (Germany)
In research, Eli Lilly (Germany) stands highest in Medicine (#11,824 of 17,978 worldwide) and Health Sciences (#14,840 of 20,462 worldwide), over all time.
- World rank, all time
- #27,658 of 42,892
- Rank in Germany
- #1,300 of 2,077
- Research works
- 318 ▼ 29% vs 2013–17
- Citations
- 9.7k 30.5 per fractional work
- Top-10% rate
- 13.8% record average 16.5%
- Open access
- 26% world 28%
What is Eli Lilly (Germany) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #11,824 of 17,978 | 18.9% | 210 | |
| Health SciencesDomain | #14,840 of 20,462 | 18.7% | 219 |
Each strip is that field’s whole ranked pool, with the notch where Eli Lilly (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
- Medicine 4.0×
- Immunology and Microbiology 2.4×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Pharmacology, Toxicology and Pharmaceutics 2.0×
- Health Professions 1.3×
- Economics, Econometrics and Finance 0.7×
- Neuroscience 0.6×
- Decision Sciences 0.4×
- Materials Science 0.2×
- Psychology 0.1×
- Computer Science 0.1×
- Dentistry 0.1×
- Business, Management and Accounting 0.1×
- Social Sciences 0.0×
Who are the top researchers at Eli Lilly (Germany)?
Ranked on the composite score, Oliver Bachmann, Carsten Henneges and Claudia Nicolay lead among researchers whose main affiliation is Eli Lilly (Germany).
- 1 Oliver Bachmann Germany · #52,079 worldwide 293 citations · 41 works
- 2 Carsten Henneges Germany · #950,457 worldwide 34 citations · 15 works
- 3 Claudia Nicolay Germany · #1,092,519 worldwide 27 citations · 15 works
- 4 Alexander Schacht Germany · #1,563,735 worldwide 3 citations · 15 works
Which keywords describe research at Eli Lilly (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Diabetes, Clinical Guidelines, Type 2 Diabetes, Heart Failure and Obesity.
- Growth Hormone
- Comorbidity
- Antipsychotic Drugs
- Insulin Resistance
- Glucose
- Treatment Guidelines
- Targeted Therapy
- Neurobiology
- Tumor Suppression
- Chemotherapy
- Depression
- Inflammation
- Continuous Glucose Monitoring
- Clinical Trials
- Metabolic Syndrome
- Glucose Control
- Epidemiology
- Type 2 Diabetes
- Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Disease
- Clinical Guidelines
- Heart Failure
- Cardiovascular Outcomes
- Obesity
- Type 1 Diabetes
- Complications
- Hypoglycemia
- Quality of Life
- Genetics
- Prevalence
- Immunotherapy
- Diabetes Mellitus
- Cancer Risk
- AMP-Activated Protein Kinase
- Metformin
- Weight Loss
- Neurocognitive Deficits
- Hormonal Regulation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycemic Control45▲ 103×4 topics
- Insulin Therapy42▲ 120×3 topics
- Cardiovascular Disease31▲ 8.8×21 topics
- Diabetes28▲ 17×13 topics
- Clinical Guidelines27▲ 28×6 topics
- Type 2 Diabetes26▲ 44×5 topics
- Heart Failure23▲ 16×8 topics
- Epidemiology22▲ 1.72×49 topics
- Cardiovascular Outcomes21▲ 159×1 topic
- Glucose Control21▲ 159×1 topic
- Obesity21▲ 8.8×14 topics
- Metabolic Syndrome20▲ 7.5×20 topics
- Type 1 Diabetes20▲ 69×2 topics
- Clinical Trials20▲ 9.9×13 topics
- Complications18▲ 11×5 topics
- Continuous Glucose Monitoring18▲ 123×1 topic
- Hypoglycemia18▲ 123×1 topic
- Inflammation16▲ 2.1×39 topics
- Quality of Life15▲ 3.6×16 topics
- Depression14▲ 6.0×13 topics
- Genetics13▲ 5.4×10 topics
- Chemotherapy13▲ 5.7×19 topics
- Prevalence10▲ 7.7×6 topics
- Tumor Suppression10▲ 27×3 topics
- Immunotherapy10▲ 4.6×14 topics
- Neurobiology10▲ 9.0×6 topics
- Diabetes Mellitus9▲ 13×6 topics
- Targeted Therapy9▲ 14×5 topics
- Cancer Risk9▲ 11×2 topics
- Treatment Guidelines9▲ 14×3 topics
- AMP-Activated Protein Kinase9▲ 58×2 topics
- Glucose9▲ 71×1 topic
- Metformin9▲ 71×1 topic
- Insulin Resistance8▲ 5.7×7 topics
- Weight Loss8▲ 16×4 topics
- Antipsychotic Drugs8▲ 48×1 topic
- Neurocognitive Deficits8▲ 48×1 topic
- Comorbidity7▲ 23×2 topics
- Hormonal Regulation7▲ 39×2 topics
- Growth Hormone7▲ 25×2 topics
Which research topics does Eli Lilly (Germany) publish most on?
By volume in 2022–2025: Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer and Diabetes and associated disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
- 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
- 3 Metabolism, Diabetes, and Cancer Molecular Biology 1 works
- 4 Diabetes and associated disorders Genetics 0 works
- 5 Breast Cancer Treatment Studies Cancer Research 0 works
- 6 Bariatric Surgery and Outcomes Surgery 0 works
- 7 Migraine and Headache Studies Psychiatry and Mental health 0 works
- 8 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 9 Diet and metabolism studies Physiology 0 works
- 10 Psoriasis: Treatment and Pathogenesis Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Eli Lilly (Germany)'s research output changed?
Output in 2018–2022 was 29% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bad Homburg
- Accadis Hochschule Bad Homburg
- Fresenius Medical Care (Germany)
- PHV Dialysezentrum
- Fresenius (Germany)
- Else Kröner-Fresenius-Stiftung
- Industrievereinigung Kunststoffverpackungen
- Meda (Germany)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.